Garofalo Financial Statements From 2010 to 2025
| GHC Stock | EUR 5.26 0.06 1.13% |
Check Garofalo Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Garofalo Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Garofalo financial statements analysis is a perfect complement when working with Garofalo Health Valuation or Volatility modules.
Garofalo |
Garofalo Health Care Company Profit Margin Analysis
Garofalo Health's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Garofalo Health Profit Margin | 0.07 % |
Most of Garofalo Health's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Garofalo Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Garofalo Health Care has a Profit Margin of 0.0705%. This is 100.63% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The profit margin for all Germany stocks is 105.55% lower than that of the firm.
Garofalo Health Care Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Garofalo Health's current stock value. Our valuation model uses many indicators to compare Garofalo Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Garofalo Health competition to find correlations between indicators driving Garofalo Health's intrinsic value. More Info.Garofalo Health Care is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Garofalo Health Care is roughly 2.00 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Garofalo Health's earnings, one of the primary drivers of an investment's value.About Garofalo Health Financial Statements
Garofalo Health stakeholders use historical fundamental indicators, such as Garofalo Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Garofalo Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Garofalo Health's assets and liabilities are reflected in the revenues and expenses on Garofalo Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Garofalo Health Care. Please read more on our technical analysis and fundamental analysis pages.
Garofalo Health Care S.p.A. operates healthcare centers in Italy. It operates 19 healthcare facilities located in Piedmont, Veneto, Tuscany, Emilia-Romagna, Lazio, and Liguria. GAROFALO HEALTH operates under Medical Care Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1187 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Garofalo Stock
Garofalo Health financial ratios help investors to determine whether Garofalo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Garofalo with respect to the benefits of owning Garofalo Health security.